The 3-(10-bromodecyl)-5-isopropyl-2-methyl-1,4-benzoquinone (1) have been synthesized and structurally characterized by mass spectrometer (LC-MS), FT-IR, 1 H-NMR and 13 C-NMR spectra. The synthesis was carried out by refluxed Thymoquinone (TQ) with bromoundecanoic acid in the presence of acetonitrile:water (2:1 v/v) for 1.5 h. Purification of the products was conducted by open-column chromatography. Determination of product is mainly observed from C-Br stretching at 562-563 cm -1 by FT-IRand the chemical shift at δ= 3.4 ppm ( 1 H-NMR) and 33-34 ppm ( 13 C-NMR). In addition, δ = 1.38-3.05 ppm ( 1 H-NMR) and 21-32 ppm ( 13 C-NMR) considered as aliphatic alkane which substituted at C-6 onThymoquinone ring. Analysis using LC-MS showed the molecular weight of 1is 382.96 g/mol. The yield of 1is 12.09% as brownishyellow liquid. Activity test of 1against the cytochrome protein (CYP) as macromolecule model revealed a good fit with IC 50 1.23 mg/mL lower than TQ (36.11 mg/mL). It is showed that compound 1 exhibit anticancer activity better than TQ.
INTRODUCTION
Thymoquinone (TQ) is a potentially active compound of black cumin seeds (Nigella sativa L) 1 . TQ have biological activity as an antioxidant, antimicrobial, anticancer and antiinflammatory effect 2 . Although it has benefits for therapy, its effectiveness and oral bioavailability are limited by poor solubility and poor lipophilicity 3 . TQ have activity for oral administration in a wide panel of animal disease models. Its revealed to be safe to consume if the doses were kept between 10-100 mg/kg body weight 4 .On otherhand, TQ ability to bind serum proteins affects and reduces its anticancer activity. 5 By this fact, the bioavalibity of TQ over oral administration is limited. Modification structure of TQ is proposed to increase the activity by addition of bromoalkyl-phosphoniumcation (TQBrP). It showed that TQBrP gave antioxidant activity in mitochondria 6 .Here, we reportedthe synthesis of TQ derivative by substitution reaction usingbromoalkyl group and analysis its activity against the cytochrome protein (CYP) as macromolecule model to determine the physicochemical properties and interactions between the receptor ligand and the active side.
EXPERIMENTAL

Materials and Methods
Thymoquinone was purchased from Sigma Aldrich with 99% purity and used without further purification.Bromoundecanoid acid and (NH 4 ) 2 S 2 O 8 were also purchased from Sigma Aldrich. Na 2 SO 4 and AgNO 3 were supplied by Merck. The solvents, that is acetonitrile, diethyl ether, chloroform, and n-hexane were obtained from Merck in pro analysis grade.
Synthesis of 3-(10-bromodesil)-5-isopropyl-2-methyl-1,4-benzoquinone
Bromoalkylation reaction of thymoquinonewas carried out by reflux. Thymoquinone (4 mmol, 0.55 g), bromoundecanoic acid (4.2 mmol, 1.12 g), AgNO 3 (2 mmol, 0,37 g), and 14 mL AcCN: H 2 O (2:1) stirred until 80 o C then added with (NH 4 ) 2 S 2 O 8 in 3 mL water and continued the reaction for 1.5 hour. The product mixture was extracted with diethyl ether. The organic was dried over Na 2 SO 4 and evaporated in vacuum. The crude product of reaction purified by chromatography column using n-hexane:chloroform (9:1) as the eluent. Productswere analyzed using TLC, FT-IR, UV-Vis, LC-MS, 1 H-and 13 C-NMR.
Activity of 3-(10-bromodesil)-5-isopropyl-2-methyl-1,4-benzoquinone
Activity of 3-(10-bromodesil)-5-isopropyl-2-methyl-1,4-benzoquinone (1)wascalculated by molecular docking using Auto Dock 4. The structure of ligand (1) was optimized by HyperChem save in .pdb format. The macromolecule cytochrome protein (CYP) were downloaded by www.pdb.org and saved in .pdb format. The structure of macromolecule should be free from water and ligand external. Docking process consists of two main step, running Auto grid (modified format changed to .gpf) and running Auto dock (format changed to .dpf). Activity analysis Auto dock include binding interaction (Ki) with minimum energy, amino acid interaction, and ligand interaction.
RESULT AND DISCUSSION
Synthesis of 3-(10-bromodesil)-5-isopropyl-2-methyl-1,4-benzoquinone
Synthesis of 3-(10-bromodesil)-5-isopropyl-2-methyl-1,4-benzoquinone (1) were summarized in Scheme 1. The addition of AgNO 3 initiated the decarboxylation reaction by the release of CO 2 from the carboxyl group to form a nucleophile. Then, theaddition of (NH 4 )S 2 O 8 in solution initiated nucleophilic substitution of alkyl bromide on the quinone ring at C-6. Substitution at C-6 is preferred over C-3 because of steric hindrance of isopropyl at C-2 is greater than methyl at C-5.It is predicted that the addition of bromoalkyl increasedthe lipophilicity of 1by the addition of non-polar substituent. The obtained product is brownish-yellow liquid in 12.09% yield. Analysis using TLC showed that compound 1 have retardation factor Rf= 0.40 (n-hexane: CHCl 3 (9:1 v/v)).The Rf of 1 is greater than TQ (Rf = 0.30) in n-hexane: CHCl 3 (9:1 v/v). It showed that compound 1has a lower polarity than TQ.Analysis using UV-Vis in 1-octanol gave λ maks 259.6 nm.The addition of bromo alkyl group in quinone ring increased the wavenumberof TQ 7 . From FT-IR analysis, compound 1showed the existence of a new peak at 562.01 cm -1 from the vibration of C-Br group. In concomitant, the decreasing of the intensity peak at 3040. Elucidation structure of product reaction was conducted by 1 H-and 13 C-NMR in CDCl 3 .
The successful of synthesis was easily identified from hydrogen splitting in aliphatic alkane at chemical shifts δ = 1.38-2.48 ppm. Methylene bonded with bromine (-CH 2 -Br) at 3.41 ppm is due electronegativity effect. The hydrogen attached toquinone ring at δ= 6.48 ppm gave the singletsplitting. It showed that alkylation only replacesthe hydrogen atom at C-6 in quinone ring. Analysis with 13 C-NMR showed that aliphatic alkane substituted in quinone ring at δ= 21-32 ppm, C-Br at δ=34.18 ppm, C=C in quinoneat δ=130-154 ppm, and C=O at δ=187-188 ppm. The chemical shift from 1 H-and 13 C-NMR was tabulated in Table 1 and Table 2 . Correlation of proton and carbon is depicted in Figure 1 .
Analysis using LC-MS showed that molecular weight of product reaction is 382.87 g/mol. From all the analysis, we success to synthesized 3-(10-bromodesil)-5-isopropyl-2-methyl-1,4-benzoquinone (1) in one-step reaction. Figure 2 . Elucidation of C1based on 1 H-NMR and 13 C-NMR
Activity of 3-(10-bromodesil)-5-isopropyl-2-methyl-1,4-benzoquinone
The activity of 1 was determined by molecular docking using cytochrome protein (CYP). Evaluated the activity of compound1is resume in Table 3 .The physicochemical properties of compounds were subjectedfor thecoefficient partition (log P), Gibbs energy (∆G o ), and inhibition constant (Ki). Visualization interaction of compound 1 with CYP macromolecule showed in Figure 2 . The activity of compound 1 has evaluated by molecular docking, and the calculation of log P carried out byHyperChem. Based on HyperChem, compound1 hasa log P value greater than TQ. Log P value has a correlation with lipophilicityof determined compound. It showed that addition bromoalkyl group in TQ is increasing the absorption rate and affinity of compound 1 to penetrate lipophilic membrane of macromolecule. The Gibbs energy (∆G o ) is energy needed by the ligand and amino acid to binding macromolecule. Lower ∆G o means that ligand can easily to bind the macromolecule. By this calculation,compound 1has ∆G o =-7.9 kcal/mol lower than TQ. Onother hand, Ki of compound1is smaller than TQ. Activity test of 1 against the cytochrome protein (CYP) as macromolecule model revealed a good fit with IC 50 1.23 mg/mL lower than TQ (36.11 mg/mL). It is showed that compound 1 exhibit anticancer activity better than TQ.
CONCLUSION AND OUTLOOKS
Synthesis of 3-(10-bromodecyl)-5-isopropyl-2-methyl-1,4-benzoquinone (1) was performedin one-step reaction by alkylation of Thymoquinonewith bromoundecanoic acid in mild condition. The substitution of the bromoalkyl into Thymoquinone ring gave the increasing activity against CYP macromolecule model compared with the parent compound. Future works will focus on antimicrobial analysis of compound 1by In-vitro and In-vivo approach. 
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